Financial results - DERMA LUX SRL

Financial Summary - Derma Lux Srl
Unique identification code: 16580877
Registration number: J22/1425/2004
Nace: 8622
Sales - Ron
393.719
Net Profit - Ron
182.781
Employee
4
The most important financial indicators for the company Derma Lux Srl - Unique Identification Number 16580877: sales in 2023 was 393.719 euro, registering a net profit of 182.781 euro and having an average number of 4 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Derma Lux Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 220.076 283.069 349.736 382.498 348.638 370.508 341.138 419.953 374.539 393.719
Total Income - EUR 221.212 283.212 349.784 383.603 350.058 370.774 341.332 421.639 379.253 398.691
Total Expenses - EUR 177.384 214.767 241.440 230.820 202.668 196.546 189.627 214.346 210.935 210.050
Gross Profit/Loss - EUR 43.828 68.445 108.344 152.782 147.390 174.227 151.705 207.293 168.318 188.641
Net Profit/Loss - EUR 36.816 57.494 91.007 146.289 143.889 170.520 148.483 203.076 164.525 182.781
Employees 6 6 6 6 6 4 4 4 0 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 5.4%, from 374.539 euro in the year 2022, to 393.719 euro in 2023. The Net Profit increased by 18.754 euro, from 164.525 euro in 2022, to 182.781 in the last year.

Check the financial reports for the company - Derma Lux Srl

Rating financiar

Financial Rating -
Derma Lux Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Derma Lux Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Derma Lux Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Derma Lux Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Derma Lux Srl - CUI 16580877

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 47.729 42.486 35.325 29.054 22.476 15.301 9.049 2.582 44.541 38.340
Current Assets 9.115 25.044 79.381 128.530 130.092 162.109 145.611 208.300 126.797 153.879
Inventories 0 0 0 0 606 0 0 0 0 0
Receivables 83 123 109 0 0 0 2.363 935 2.570 6.734
Cash 9.033 24.921 79.272 128.530 129.486 162.109 143.248 207.365 124.226 147.145
Shareholders Funds 36.916 57.595 91.107 146.388 143.986 170.614 148.576 203.167 164.616 182.872
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 19.928 9.935 23.599 11.196 8.582 6.796 6.084 7.714 6.721 9.348
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 153.879 euro in 2023 which includes Inventories of 0 euro, Receivables of 6.734 euro and cash availability of 147.145 euro.
The company's Equity was valued at 182.872 euro, while total Liabilities amounted to 9.348 euro. Equity increased by 18.754 euro, from 164.616 euro in 2022, to 182.872 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Derma Lux Srl

Comments - Derma Lux Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.